374 related articles for article (PubMed ID: 15084273)
1. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF.
Lesley R; Xu Y; Kalled SL; Hess DM; Schwab SR; Shu HB; Cyster JG
Immunity; 2004 Apr; 20(4):441-53. PubMed ID: 15084273
[TBL] [Abstract][Full Text] [Related]
2. Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells.
Fletcher CA; Sutherland AP; Groom JR; Batten ML; Ng LG; Gommerman J; Mackay F
Eur J Immunol; 2006 Sep; 36(9):2504-14. PubMed ID: 16906535
[TBL] [Abstract][Full Text] [Related]
3. Act1, a negative regulator in CD40- and BAFF-mediated B cell survival.
Qian Y; Qin J; Cui G; Naramura M; Snow EC; Ware CF; Fairchild RL; Omori SA; Rickert RC; Scott M; Kotzin BL; Li X
Immunity; 2004 Oct; 21(4):575-87. PubMed ID: 15485634
[TBL] [Abstract][Full Text] [Related]
4. Effect of cell:cell competition and BAFF expression on peripheral B cell tolerance and B-1 cell survival in transgenic mice expressing a low level of Igkappa-reactive macroself antigen.
Aït-Azzouzene D; Gavin AL; Skog P; Duong B; Nemazee D
Eur J Immunol; 2006 Apr; 36(4):985-96. PubMed ID: 16511898
[TBL] [Abstract][Full Text] [Related]
5. BAFF AND APRIL: a tutorial on B cell survival.
Mackay F; Schneider P; Rennert P; Browning J
Annu Rev Immunol; 2003; 21():231-64. PubMed ID: 12427767
[TBL] [Abstract][Full Text] [Related]
6. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation.
Shulga-Morskaya S; Dobles M; Walsh ME; Ng LG; MacKay F; Rao SP; Kalled SL; Scott ML
J Immunol; 2004 Aug; 173(4):2331-41. PubMed ID: 15294946
[TBL] [Abstract][Full Text] [Related]
7. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome.
Groom J; Kalled SL; Cutler AH; Olson C; Woodcock SA; Schneider P; Tschopp J; Cachero TG; Batten M; Wheway J; Mauri D; Cavill D; Gordon TP; Mackay CR; Mackay F
J Clin Invest; 2002 Jan; 109(1):59-68. PubMed ID: 11781351
[TBL] [Abstract][Full Text] [Related]
8. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology.
Sasaki Y; Casola S; Kutok JL; Rajewsky K; Schmidt-Supprian M
J Immunol; 2004 Aug; 173(4):2245-52. PubMed ID: 15294936
[TBL] [Abstract][Full Text] [Related]
9. The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF.
Tardivel A; Tinel A; Lens S; Steiner QG; Sauberli E; Wilson A; Mackay F; Rolink AG; Beermann F; Tschopp J; Schneider P
Eur J Immunol; 2004 Feb; 34(2):509-18. PubMed ID: 14768056
[TBL] [Abstract][Full Text] [Related]
10. B cell-activating factor is a novel diagnosis parameter for asthma.
Kang JS; Yoon YD; Ahn JH; Kim SC; Kim KH; Kim HM; Moon EY
Int Arch Allergy Immunol; 2006; 141(2):181-8. PubMed ID: 16899986
[TBL] [Abstract][Full Text] [Related]
11. The BAFF/APRIL system: an important player in systemic rheumatic diseases.
Mackay F; Sierro F; Grey ST; Gordon TP
Curr Dir Autoimmun; 2005; 8():243-65. PubMed ID: 15564724
[TBL] [Abstract][Full Text] [Related]
12. Actions of BAFF in B cell maturation and its effects on the development of autoimmune disease.
Melchers F
Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii25-7. PubMed ID: 14532143
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the B cell receptor repertoire and self-reactivity by BAFF.
Ota M; Duong BH; Torkamani A; Doyle CM; Gavin AL; Ota T; Nemazee D
J Immunol; 2010 Oct; 185(7):4128-36. PubMed ID: 20817867
[TBL] [Abstract][Full Text] [Related]
14. The role of BAFF in immune function and implications for autoimmunity.
Kalled SL
Immunol Rev; 2005 Apr; 204():43-54. PubMed ID: 15790349
[TBL] [Abstract][Full Text] [Related]
15. BAFF mediates survival of peripheral immature B lymphocytes.
Batten M; Groom J; Cachero TG; Qian F; Schneider P; Tschopp J; Browning JL; Mackay F
J Exp Med; 2000 Nov; 192(10):1453-66. PubMed ID: 11085747
[TBL] [Abstract][Full Text] [Related]
16. Peripheral B lymphocyte tolerance.
Gavin A; Aït-Azzouzene D; Mårtensson A; Duong B; Verkoczy L; Vela JL; Skog P; Nemazee D
Keio J Med; 2004 Sep; 53(3):151-8. PubMed ID: 15477728
[TBL] [Abstract][Full Text] [Related]
17. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.
Mackay F; Woodcock SA; Lawton P; Ambrose C; Baetscher M; Schneider P; Tschopp J; Browning JL
J Exp Med; 1999 Dec; 190(11):1697-710. PubMed ID: 10587360
[TBL] [Abstract][Full Text] [Related]
18. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches.
Thien M; Phan TG; Gardam S; Amesbury M; Basten A; Mackay F; Brink R
Immunity; 2004 Jun; 20(6):785-98. PubMed ID: 15189742
[TBL] [Abstract][Full Text] [Related]
19. BAFF and the regulation of B cell survival.
Schneider P; Tschopp J
Immunol Lett; 2003 Jul; 88(1):57-62. PubMed ID: 12853163
[TBL] [Abstract][Full Text] [Related]
20. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells.
Ng LG; Sutherland AP; Newton R; Qian F; Cachero TG; Scott ML; Thompson JS; Wheway J; Chtanova T; Groom J; Sutton IJ; Xin C; Tangye SG; Kalled SL; Mackay F; Mackay CR
J Immunol; 2004 Jul; 173(2):807-17. PubMed ID: 15240667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
